Iconic Labs PLC (LSE:ICON) has converted 20 Convertible Notes into equity, issuing 1,269,841 new ordinary shares at a conversion price of £0.01575 per share, equivalent to £20,000 of principal. Admission of the new shares to trading on the London Stock Exchange’s Main Market is expected to take place around 26 February 2026.
The newly issued shares will rank equally with the company’s existing ordinary shares. Following the conversion, Iconic Labs’ total issued share capital has increased to 15,153,868 shares. The expanded share base changes the company’s voting rights structure and may require certain shareholders to review and, if necessary, update disclosures in line with UK transparency and notification rules.
The company’s outlook continues to be weighed down by weak underlying financial conditions, including minimal revenue generation, ongoing operating losses, negative equity and sustained cash outflows. While technical indicators show limited positive signals, they remain insufficient to counterbalance fundamental risks. Valuation metrics are also constrained by a negative price-to-earnings ratio and the absence of dividend yield support.
More about Iconic Labs plc
Iconic Labs PLC is a London Stock Exchange-listed company whose ordinary shares underpin shareholder voting rights and regulatory reporting obligations. Investors closely track the company’s capital structure and equity issuance activity in accordance with UK financial market regulations.
Leave a Reply